Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Shanghai Rongtai Health Technology's annualized ROCE % for the quarter that ended in Mar. 2026 was 9.32%.
Shanghai Rongtai Health Technology (SHSE:603579) ROCE % Explanation
ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.
Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.
Shanghai Rongtai Health Technology ROCE % Related Terms
Shanghai Rongtai Health Technology ROCE % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
(1) Note:
The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai Rongtai Health Technology (SHSE:603579) has a ROCE % of 9.32% as of Mar. 2026.
Is Shanghai Rongtai Health Technology's ROCE % too high?
Shanghai Rongtai Health Technology's current ROCE % is 9.32%. The Travel & Leisure industry median ROCE % is 6.08. Shanghai Rongtai Health Technology's value of 9.32% is 53.3% above this industry median. Overall, Shanghai Rongtai Health Technology has a GF Score™ of 68/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Shanghai Rongtai Health Technology's ROCE % compare to AS and HAS?
Shanghai Rongtai Health Technology's ROCE % of 9.32% can be compared against companies in the Travel & Leisure industry. The industry median ROCE % is 6.08. Shanghai Rongtai Health Technology's value of 9.32% is 53.3% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Travel & Leisure company?
The median ROCE % among Travel & Leisure companies is 6.08, based on 833 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shanghai Rongtai Health Technology's current ROCE % of 9.32% is 53.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Travel & Leisure industry, the median ROCE % is 6.08 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shanghai Rongtai Health Technology's current ROCE % is 9.32%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Rongtai Health Technology stock overvalued right now?
Based on GuruFocus' analysis, Shanghai Rongtai Health Technology (SHSE:603579) is currently considered Fairly Valued. The stock's GF Value™ is ¥15.92, compared to a current price of ¥16.30 — trading 2.4% above its estimated fair value. The current ROCE % is 9.32% and 53.3% above the Travel & Leisure industry median of 6.08. Shanghai Rongtai Health Technology's overall GF Score™ is 68/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Shanghai Rongtai Health Technology (SHSE:603579), the current ROCE % is 9.32% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shanghai Rongtai Health Technology (SHSE:603579) Overvalued in 2026?
Based on GuruFocus' analysis, Shanghai Rongtai Health Technology stock appears to be overvalued.
The current stock price of ¥16.30 is trading 2.4% above its estimated GF Value™ of ¥15.92.
GuruFocus considers Shanghai Rongtai Health Technology to be Fairly Valued.
Key valuation signals for SHSE:603579:
ROCE %: 9.32%
GF Value™: ¥15.92 vs. price of ¥16.30 (2.4% above fair value)
Industry Position: 53.3% above the Travel & Leisure median
No single metric tells the full story. See the SHSE:603579 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shanghai Rongtai Health Technology Business Description
Shanghai Rongtai Health Technology Corp Ltd is a China based company engaged in development, manufacturing and marketing of massage equipment. It also offers technology health solutions. The company's products include eye massager, massage chair series, mini massage chair, partial massage series products, massage stick, and waist massager.
68GF Score
Get the complete analysis for SHSE:603579
ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:603579 has been successfully added to your 
